Synthesis and anticonvulsant activity of new 2-substituted-5-[2-(2-fluorophenoxy) phenyl]-1, 3, 4-oxadiazoles and 1, 2, 4-triazoles A Almasirad, SA Tabatabai, M Faizi, A Kebriaeezadeh, N Mehrabi, ... Bioorganic & medicinal chemistry letters 14 (24), 6057-6059, 2004 | 497 | 2004 |
Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1, 3, 4-oxadiazoles A Zarghi, SA Tabatabai, M Faizi, A Ahadian, P Navabi, V Zanganeh, ... Bioorganic & medicinal chemistry letters 15 (7), 1863-1865, 2005 | 310 | 2005 |
Mouse model of Timothy syndrome recapitulates triad of autistic traits PL Bader, M Faizi, LH Kim, SF Owen, MR Tadross, RW Alfa, GCL Bett, ... Proceedings of the National Academy of Sciences 108 (37), 15432-15437, 2011 | 213 | 2011 |
Errors in preparation and administration of intravenous medications in the intensive care unit of a teaching hospital: an observational study F Fahimi, P Ariapanah, M Faizi, B Shafaghi, R Namdar, MT Ardakani Australian critical care 21 (2), 110-116, 2008 | 197 | 2008 |
Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists AM Kleschevnikov, PV Belichenko, M Faizi, LF Jacobs, K Htun, ... Journal of Neuroscience 32 (27), 9217-9227, 2012 | 187 | 2012 |
Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome A Salehi, M Faizi, D Colas, J Valletta, J Laguna, R Takimoto-Kimura, ... Science translational medicine 1 (7), 7ra17-7ra17, 2009 | 179 | 2009 |
Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer M Faizi, PL Bader, C Tun, A Encarnacion, A Kleschevnikov, P Belichenko, ... Neurobiology of disease 43 (2), 397-413, 2011 | 155 | 2011 |
Total phenolic and flavonoid content and antibacterial activity of Punica granatum L. var. pleniflora flowers (Golnar) against bacterial strains causing foodborne diseases A Mahboubi, J Asgarpanah, PN Sadaghiyani, M Faizi BMC complementary and alternative medicine 15 (1), 1-7, 2015 | 122 | 2015 |
Thy1‐hAPPLond/Swe+ mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function M Faizi, PL Bader, N Saw, TVV Nguyen, S Beraki, T Wyss‐Coray, ... Brain and behavior 2 (2), 142-154, 2012 | 101 | 2012 |
Design and synthesis of new 2-substituted-5-(2-benzylthiophenyl)-1, 3, 4-oxadiazoles as benzodiazepine receptor agonists A Zarghi, M Faizi, B Shafaghi, A Ahadian, HR Khojastehpoor, V Zanganeh, ... Bioorganic & medicinal chemistry letters 15 (12), 3126-3129, 2005 | 91 | 2005 |
Design, synthesis, pharmacological evaluation, and docking study of new acridone-based 1, 2, 4-oxadiazoles as potential anticonvulsant agents M Mohammadi-Khanaposhtani, M Shabani, M Faizi, I Aghaei, R Jahani, ... European journal of medicinal chemistry 112, 91-98, 2016 | 90 | 2016 |
Reversal effects of crocin on amyloid β-induced memory deficit: Modification of autophagy or apoptosis markers F Asadi, AH Jamshidi, F Khodagholi, A Yans, L Azimi, M Faizi, L Vali, ... Pharmacology Biochemistry and Behavior 139, 47-58, 2015 | 86 | 2015 |
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice A Rahimi, M Faizi, F Talebi, F Noorbakhsh, F Kahrizi, N Naderi Neuroscience 290, 279-287, 2015 | 79 | 2015 |
Using mouse models to explore genotype–phenotype relationship in Down syndrome A Salehi, M Faizi, PV Belichenko, WC Mobley Mental retardation and developmental disabilities research reviews 13 (3 …, 2007 | 76 | 2007 |
Toxicity of cuprizone a Cu2+ chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction M Faizi, A Salimi, E Seydi, P Naserzadeh, M Kouhnavard, A Rahimi, ... Toxicology mechanisms and methods 26 (4), 276-283, 2016 | 72 | 2016 |
Antiulcer activities of liquorice and its derivatives in experimental gastric lesion induced by ibuprofen in rats AR Dehpour, ME Zolfaghari, T Samadian, F Kobarfard, M Faizi, M Assari International journal of pharmaceutics 119 (2), 133-138, 1995 | 71 | 1995 |
Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests A Haj-Mirzaian, N Kordjazy, A Haj-Mirzaian, S Ostadhadi, M Ghasemi, ... Psychopharmacology 232, 3551-3561, 2015 | 59 | 2015 |
Design and synthesis of new 2-substituted-5-[2-(2-halobenzyloxy) phenyl]-1, 3, 4-oxadiazoles as anticonvulsant agents A Zarghi, Z Hajimahdi, S Mohebbi, H Rashidi, S Mozaffari, S Sarraf, ... Chemical and Pharmaceutical Bulletin 56 (4), 509-512, 2008 | 59 | 2008 |
Schizophrenia induces oxidative stress and cytochrome C release in isolated rat brain mitochondria: a possible pathway for induction of apoptosis and neurodegeneration M Faizi, A Salimi, M Rasoulzadeh, P Naserzadeh, J Pourahmad Iranian journal of pharmaceutical research: IJPR 13 (Suppl), 93, 2014 | 56 | 2014 |
Synthesis and pharmacological evaluation of new 2-substituted-5-{2-[(2-halobenzyl) thio) phenyl}-1, 3, 4-oxadiazoles as anticonvulsant agents A Zarghi, S Hamedi, F Tootooni, B Amini, B Sharifi, M Faizi, SA Tabatabai, ... Scientia pharmaceutica 76 (2), 185-202, 2008 | 56 | 2008 |